NIH-funded research NIH-funded research

Multimodal AI to improve genetic diagnosis of congenital heart disease

Official title: Multimodal AI for Precise Clinical and Genetic Diagnosis of Congenital Heart Disease

Funded at Baylor College of Medicine · NIH-11573169 · Data updated 2026-11-12

A big AI project will help doctors and families by better identifying genetic causes of congenital heart defects using imaging, medical data, and genome information.

More Heart Disease research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBaylor College of Medicine
NIH-funded
Lab location1 site (Houston, United States)
Project startSeptember 8, 2025
Project endSeptember 7, 2027
Funding year2026
Award (this year)$2,000,259
NIH project number3OT2OD038054-01S1
Project IDNIH-11573169 on NIH RePORTER

Who could benefit from this research

Could help

Patients with congenital heart disease and their families whose care may be influenced by genetic diagnosis and personalized treatment strategies.

Less likely to help

Patients whose CHD is not linked to identifiable genetic variants or who do not undergo genomic testing may not benefit.

What this research studies

This project develops an AI system that combines data from heart imaging, medical records, and whole-genome sequencing to pinpoint genes likely involved in congenital heart disease. It aims to prioritize candidate genes and automatically identify likely disease-causing variants, making genetic diagnosis faster and more accurate. The work will be designed with input from patients, families, clinicians, and other stakeholders to address ethical considerations and fit into clinical workflows at Baylor College of Medicine. If successful, it could lead to more personalized prognoses and treatment plans for children with CHD.

Why it matters

Potential benefit: Could shorten time to precise genetic diagnosis and improve tailored management for children with CHD.

How similar studies have gone: Previous efforts show promise in AI-assisted genetic variant prioritization, but multimodal integration in CHD is an emerging area with potential for breakthrough.

Where this research is happening

  • Baylor College of Medicine
    Houston, United States
    Active

Researchers

  • Principal investigator: Milosavljevic, Aleksandar — Baylor College of Medicine
  • Study coordinator: Milosavljevic, Aleksandar

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.